Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Perturbation of mTOR pathway shapes the MHC I immunopeptidome of cancer cells

EF 2009-10

Résumé
The major histocompatibility complex class I (MHC I) is a genomic region encoding for a group of cell surface molecules that play a crucial role in the adaptive immune system. In absence of infection, MHC I molecules present at the cell surface, peptides that derive from self proteins. These complexes are globally referred to as the self MHC I immunopeptidome (sMII). Although it is known that its genesis is tightly linked to protein synthesis and degradation, the molecular composition of the sMII is still poorely defined. To better understand how the sMII is generated, we wanted to assess if the perturbation of a major signaling pathway could induce changes in the genesis and global composition of the MHC I associated peptides. We believe that mTOR pathway plays an important role in this process mainly because its role is crucial in the regulation of protein translation and degradation and because it is considered as the most frequently amplified pathway in cancers. Previous studies in our laboratory showed that disrupting mTOR pathway has a drastic effect on the global composition of the sMII and that it increases presentation of the MHC I - peptides complexes at the cell surface. In this curent study, we want to determine the mecanisms involved in the increase of cell surface expression of MHC I - peptides complexes in rapamycin treated cells. Our hypothesis is that disrupting mTOR pathway will induce major changes in the regulation of protein translation and that this will result in an increased proportion of misfolded newly synthesized proteins. These proteins will be rapidly degraded, therefore affecting the content of the sMII. We believe that understanting the sMII of cells in which mTOR pathway has been perturbed will provide a unique perspective on the biology of cancer cells and provide new information for the develpment of immunotherapies for cancer.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
201288
Name
Vincent Krystel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Perturbation of mTOR pathway shapes the MHC I immunopeptidome of cancer cells
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cellular Biology; Immunopeptidome; Lymphocytes; Mass Spectrometry; Mhc I; Molecular Biology; Mtor
Abstract
The major histocompatibility complex class I (MHC I) is a genomic region encoding for a group of cell surface molecules that play a crucial role in the adaptive immune system. In absence of infection, MHC I molecules present at the cell surface, peptides that derive from self proteins. These complexes are globally referred to as the self MHC I immunopeptidome (sMII). Although it is known that its genesis is tightly linked to protein synthesis and degradation, the molecular composition of the sMII is still poorely defined. To better understand how the sMII is generated, we wanted to assess if the perturbation of a major signaling pathway could induce changes in the genesis and global composition of the MHC I associated peptides. We believe that mTOR pathway plays an important role in this process mainly because its role is crucial in the regulation of protein translation and degradation and because it is considered as the most frequently amplified pathway in cancers. Previous studies in our laboratory showed that disrupting mTOR pathway has a drastic effect on the global composition of the sMII and that it increases presentation of the MHC I - peptides complexes at the cell surface. In this curent study, we want to determine the mecanisms involved in the increase of cell surface expression of MHC I - peptides complexes in rapamycin treated cells. Our hypothesis is that disrupting mTOR pathway will induce major changes in the regulation of protein translation and that this will result in an increased proportion of misfolded newly synthesized proteins. These proteins will be rapidly degraded, therefore affecting the content of the sMII. We believe that understanting the sMII of cells in which mTOR pathway has been perturbed will provide a unique perspective on the biology of cancer cells and provide new information for the develpment of immunotherapies for cancer.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vincent, Krystel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~